A recent study led by scientists at the University of Tennessee showed that up to 11 percent of patients with COVID-19 have liver comorbidities. And 14 percent to 53 percent showed increased levels of liver enzymes - such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) during the progression of the illness. Increased levels of liver enzymes can mean that a person's liver is at least temporarily damaged.
Some patients have a very severe injury in the liver due to COVID. The most common are swelling in the liver, jaundice which means yellow discolouration of eyes and urine and derailment of liver function tests.
"It is commonly seen that nonspecific inflammation due to COVID is very common in the liver and manifests in various forms," Dr. Shubham Vatsya, Consultant - Gastroenterology at Fortis Escorts Hospital, Faridabad, told IANS.
"A wide range of liver injuries seen in COVID infection can be completely asymptomatic. It can cause jaundice or it can cause liver failure," added Dr. Jatin Agrawal, Associate Consultant, Gastroenterology. Max Hospital, Saket.
Further, people with cirrhosis (liver scarring) may be at increased risk of COVID-19. Some studies have also shown that people with pre-existing liver disease such as chronic liver disease, cirrhosis, or related complications who were diagnosed with COVID-19 are at a higher risk of death than people without pre-existing liver disease.